Health Care

Swiss giant Novartis to buy US-based AveXis in $8.7B deal

Swiss pharmaceuticals giant Novartis says it has agreed to buy the U.S.-based gene therapy company AveXis Inc. for $8.7 billion, part of its goal to become a leader in the treatment of neurodegenerative diseases.

FDA orders recall of salmonella-tainted herbal supplement

U.S. health authorities are ordering a Las Vegas company to pull its herbal supplements off the market because some of its products tested positive for salmonella, part of a nationwide outbreak linked to the ingredient kratom.

EPA to ease back emissions standards

Environmental regulators announced on Monday they will ease emissions standards for cars and trucks, saying that a timeline put in place by President Obama was not appropriate and set standards "too high."